Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Tumor cells

Tumor cells <h2>Tumor cells</h2> <h3>a single signal to divide and conquer?</h3> Cdc2 (red) promotes migration by phosphorylating caldesmon (green) in membrane ruffles. Metastatic tumor cells are dangerous because they not only proliferate but also migrate and invade other tissues. On page 817 , Manes et al. reach the surprising conclusion that the cyclin- dependent kinase cdc2 regulates both of these activities. The work identifies a novel signaling pathway and points to a promising new strategy for targeting metastatic cells, but it may also force a reevaluation of some current drug development efforts. Cdc2 is well known as a cell cycle regulator, but previous work had shown that it also phosphorylates multiple cytoskeletal proteins. In the new work, the authors found that αvβ3 integrin expression in a prostate cancer cell line increases cdc2 mRNA and protein levels and leads to an increase in cdc2 kinase activity. Using cyclin B2 as a cofactor, cdc2 acts in ruffles to phosphorylate the cytoskeleton-associated protein caldesmon. Others have recently shown that this phosphorylation relieve an inhibition of actin polymerization, and thus may be pro-migratory. The results show that, besides regulating the cell cycle, cdc2 also acts as a downstream effector of αvβ3 to regulate cell http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Cell Biology Rockefeller University Press

Loading next page...
 
/lp/rockefeller-university-press/tumor-cells-30W8omFKBJ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Rockefeller University Press
Copyright
© 2003 Rockefeller University Press
ISSN
0021-9525
eISSN
1540-8140
DOI
10.1083/jcb1614iti1
Publisher site
See Article on Publisher Site

Abstract

<h2>Tumor cells</h2> <h3>a single signal to divide and conquer?</h3> Cdc2 (red) promotes migration by phosphorylating caldesmon (green) in membrane ruffles. Metastatic tumor cells are dangerous because they not only proliferate but also migrate and invade other tissues. On page 817 , Manes et al. reach the surprising conclusion that the cyclin- dependent kinase cdc2 regulates both of these activities. The work identifies a novel signaling pathway and points to a promising new strategy for targeting metastatic cells, but it may also force a reevaluation of some current drug development efforts. Cdc2 is well known as a cell cycle regulator, but previous work had shown that it also phosphorylates multiple cytoskeletal proteins. In the new work, the authors found that αvβ3 integrin expression in a prostate cancer cell line increases cdc2 mRNA and protein levels and leads to an increase in cdc2 kinase activity. Using cyclin B2 as a cofactor, cdc2 acts in ruffles to phosphorylate the cytoskeleton-associated protein caldesmon. Others have recently shown that this phosphorylation relieve an inhibition of actin polymerization, and thus may be pro-migratory. The results show that, besides regulating the cell cycle, cdc2 also acts as a downstream effector of αvβ3 to regulate cell

Journal

The Journal of Cell BiologyRockefeller University Press

Published: May 26, 2003

There are no references for this article.